Myobloc 10,000 units/2 ML vial 2ML
Ended Awarded
- Contract number
- SPE2DB25FDL89
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,883
Award facts
- Contract value 100% obligated
- $47,882.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,882.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 10,000 units of Myobloc 2 ML vials. The contract, awarded on September 16, 2025, with an ultimate completion date of October 7, 2025, carries no set-aside designation. Myobloc is a botulinum toxin product used for medical and therapeutic applications, and this delivery order represents a continuation of DMS Pharmaceutical Group's ongoing supply relationship with the Defense Logistics Agency for pharmaceutical products supporting Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and effective through November 2026. Under this master contract vehicle, the Defense Logistics Agency issues firm fixed-price delivery orders for comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group's established position as a critical supplier within the federal pharmaceutical supply chain enables efficient distribution of specialized pharmaceutical products to Department of Defense healthcare sites across multiple locations.
Quick answers
Who was awarded contract SPE2DB25FDL89?
SPE2DB25FDL89 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FDL89 worth?
The government has obligated $47,883 on SPE2DB25FDL89.
Is contract SPE2DB25FDL89 an order under another contract?
Yes. SPE2DB25FDL89 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL89 competed?
The extent of competition for SPE2DB25FDL89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award